TGA Seeks Feedback On Updated Recall Procedure For Drugs And Devices
This article was originally published in Clinica
Executive Summary
Australia's Therapeutic Goods Administration is seeking feedback on proposed revisions to its recall procedure for drugs and medical devices.
You may also be interested in...
New Recall Procedures For Australian Therapeutic Goods Come Into Play
As of Jan. 15, sponsors of therapeutic goods in Australia must follow new recall procedures, which have been updated to ensure they are consistent with current regulatory best practice.
New Recall Procedures For Australian Therapeutic Goods Come Into Play
As of Jan. 15, sponsors of therapeutic goods in Australia must follow new recall procedures, which have been updated to ensure they are consistent with current regulatory best practice.
Outlook Turns To Marketing Strategy After Scoring EU First For Ophthalmic Bevacizumab
Outlook Therapeutics’ intravitreally injected Lytenava has won the thumbs up from the European Medicines Agency. The company is assessing both direct commercialization of the product and partnering in Europe on a country-by-country basis.